The oncoprotein, nuclear factor erythroid 2-related factor 2 (NRF2), is a master regulator of the antioxidant response pathway and serves as a key pathological transcription factor in diseases such as cancer and atherosclerosis (Kawai et al., 2011). The gene discussed is NFE2L2; the disease is cancer.